Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

Study Suggests Scalp Cooling Effective in Hair Preservation

Wednesday, December 14, 2016
Chemotherapy-induced hair loss is distressing for many women undergoing adjuvant therapy for breast cancer. Scalp cooling to reduce, or hopefully prevent, hair loss has been used around the world but has not been utilized as frequently in the US. It’s postulated that cooling the scalp during chemotherapy administration causes cutaneous vasoconstriction, which in turn reduces blood flow to hair follicles and cellular uptake of the chemotherapy.

US researchers conducted a multicenter randomized controlled prospective trial to evaluate the safety and efficacy of the Orbis Paxman Hair Loss Prevention System (OPHLPS) in reducing chemotherapy-induced alopecia (of note, some of the researchers had financial relationships with this company). Women with stage I/II breast cancer scheduled to receive neoadjuvant or adjuvant anthracycline- or taxane-based chemotherapy for at least 4 cycles were eligible to participate in the study. Participants were randomized in a 2:1 ratio to scalp cooling or no cooling. Scalp cooling was done using the OPHLPS 30 minutes prior to, during, and 90 minutes after each chemotherapy treatment.

At the time of the interim analysis, which were presented at the San Antonio Breast Cancer Symposium in December 2016, 95 women in the cooling group and 47 women in the usual care group (no cooling) completed 4 cycles of chemotherapy. About half of the patients in the cooling group, (n = 48; 50.5%) preserved their hair, whereas none of the 47 patients in the no-cooling group had hair preservation.

Researchers concluded that scalp cooling using OPHLP is effective in hair preservation and should become available for patients who receive chemotherapy for early breast cancer. Find more on the study here.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.